# Application of Amyloid PET in Cerebral Amyloid Angiopathy

> **NCT03542656** · PHASE3 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 160 (actual)

## Conditions studied

- Cerebral Amyloid Angiopathy
- Intracranial Hemorrhages
- Alzheimer Disease

## Interventions

- **DRUG:** amyloid PET

## Key facts

- **NCT ID:** NCT03542656
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-11
- **Primary completion:** 2016-02-17
- **Final completion:** 2018-03-22
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542656, "Application of Amyloid PET in Cerebral Amyloid Angiopathy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03542656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*